54881-49-1

Basic information

• Product Name: 2-CHLORO-3-METHOXYBENZALDEHYDE
• Synonyms: 2-CHLORO-3-METHOXYBENZALDEHYDE,98.0+%(GC);2-Chloro-m-anisaldehyde;2-Chloro-3-methoxybenzaldehyde 97%
• CAS NO: 54881-49-1
• Molecular Formula: C₈H₇ClO₂
• Molecular Weight: 170.59
• Product Categories: Aldehydes;C8;Carbonyl Compounds
• Mol File: 54881-49-1.mol

Chemical Properties

• Melting Point: 56-60 °C(lit.)
• Boiling Point: 260℃
• Flash Point: 115℃
• Appearance: /
• Density: 1.244
• Vapor Pressure: 0.013mmHg at 25°C
• Refractive Index: 1.564
• CAS DataBase Reference: 2-CHLORO-3-METHOXYBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-3-METHOXYBENZALDEHYDE(54881-49-1)
• EPA Substance Registry System: 2-CHLORO-3-METHOXYBENZALDEHYDE(54881-49-1)

Safety Data

• Hazard Codes: Xn,N
• Statements: 22-36/37/38-50
• Safety Statements: 26-36-45-60-61
• RIDADR: UN 3077 9/PG 3
• WGK Germany: 2
• HazardClass: 9
• PackingGroup: III
• Hazardous Substances Data: 54881-49-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Chloro-3-methoxybenzaldehyde is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs and medicinal compounds. Its unique structure allows for the creation of a wide range of organic compounds that can be tailored for specific therapeutic applications.
Used in Agricultural Chemicals Industry:
In the agricultural sector, 2-Chloro-3-methoxybenzaldehyde is employed as an intermediate in the production of agricultural chemicals. Its chemical properties make it suitable for the development of compounds that can be used in crop protection and other agricultural applications.
Used in Dyes Industry:
2-Chloro-3-methoxybenzaldehyde is utilized in the dyes industry as an intermediate for the synthesis of various dyes. Its chemical structure contributes to the creation of dyes with specific color properties and characteristics, making it a valuable component in the production of a diverse array of dyes.
Used in Research and Development Laboratories:
2-Chloro-3-methoxybenzaldehyde is commonly used in research and development laboratories for its role in the synthesis of new compounds and the exploration of its potential applications in various fields. Its versatility and reactivity make it an essential tool for scientists and researchers working on the development of new materials and products.

InChI:InChI=1/C8H7ClO2/c1-11-7-4-2-3-6(5-10)8(7)9/h2-5H,1H3

Upstream product

• 591-31-1 3-methoxy-benzaldehyde 
• 56962-10-8 2-chloro-3-hydroxybenzaldehyde 
• 74-88-4 methyl iodide 
• 100-83-4 meta-hydroxybenzaldehyde 
• 77-78-1 dimethyl sulfate 
• 52516-43-5 2-chloro-3-methoxybenzyl alcohol 
• 33234-36-5 2-chloro-3-methoxybenzoic acid 

Downstream Products

• 1133-58-0 2'-Chlor-3'-methoxybutyrophenon 
• 876300-83-3 6-Bromo-3-(2-chloro-3-methoxyphenyl)[1,2,4]triazolo[4,3-a]pyridine 
• 133841-05-1 7-methoxy-1H-indazole 
• 1372790-58-3 2-chloro-1-methoxy-3-vinylbenzene 
• 1307255-38-4 tert-butyl (3-endo)-3-(3-acetyl-2-chlorophenoxy)-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1307255-37-3 1-(2-chloro-3-methoxyphenyl)ethanone 

Relevant articles and documents

Stereoselective Synthesis of the Benzodihydropentalene Core of the Fijiolides

An efficient stereoselective synthesis of the enantiomer of the benzodihydropentalene core of fijiolides A and B has been achieved. The asymmetric conjugate addition of styrylboronic acid to an indenone produced the first stereocenter. Ring C was installe

Stereoselective isomerizations of 4-(2′-chloro-3′-methoxyphenyl)-2,5-dimethyl-1,3-dioxolanes: Stereochemistry and conformation of the product 2-benzopyrans

Stereoselective isomerization of rel-(2R,4S,5R)-4-(2′-chloro-3′-methoxyphenyl)-2,5-dimethyl-1, 3-dioxolane 5 with titanium(IV) chloride afforded solely rel-(1R,3R,4S)-5-chloro-4-hydroxy-6-methoxy-1,3-dimethyl-2-benzopyran 17 in high yield in which the con

BRUTON'S TYROSINE KINASE INHIBITORS

Bruton's tyrosine kinase (Btk) inhibitors have the following Formula (I).

ALKOXY PYRAZOLES AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS

The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6 and R7 are as defined herein. The inventi

DIHYDROPYRIDINE DERIVATIVES

The present invention relates to dihydropyridine derivatives having general formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 is (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, phenyl, (1-5C)heteroaryl R2, R3 are independently (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl, (1-4C)alkoxy, (24C)alkenyloxy, (2-4C)alkynyloxy, halogen X is SO2, CH2, C(O) or X is absent R4 is (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, (3-6C)cycloalkyl, (3-6C)cycloalkenyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl, (2-6C)heterocycloalkyl(14C)alkyl, (6-1 OC)aryl, (6-10C)aryl(1-4C)alkyl, (1-9C)heteroaryl or (1-9C)heteroaryl(14C)alkyl. The compounds are useful for the treatment of fertility disorders.

BICYCLONONENE DERIVATIVES AS RENIN INHIBITORS

The invention relates to novel bicyclononene derivatives of Formula (I); and the use thereof as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as inhibitors of renin.

DIHYDROPYRIDINE DERIVATIVES

The present invention relates to dihydropyridine derivatives having general formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 is (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, phenyl, (1-5C)heteroaryl R2, R3 are independently (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl, (1-4C)alkoxy, (2-4C)alkenyloxy, (2-4C)alkynyloxy, halogen X is SO2, CH2, C(O) or X is absent R4 is (1-6C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, (3-6C)cycloalkyl, (3-6C)cycloalkenyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl, (2-6C)heterocycloalkyl(1-4C)alkyl, (6-1 OC)aryl, (6-10C)aryl(1-4C)alkyl, (1-9C)heteroaryl or (1-9C)heteroaryl(1-4C)alkyl. The compounds are useful for the treatment of fertility disorders.

PYRIMIDINE-2,4-DIONE DERIVATIVES AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS

GnRH receptor antagonists are disclosed that have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure formula (I) wherein R1a, R1b, R2a, R2b, R3, R4, R5, R6, R7 and X are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.

PYRIMIDINE-2, 4-DIONE DERIVATIVES AS GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS

GnRH receptor antagonists are disclosed that have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein R1a, R1b, R1c, R2a, R2b, R3, R4, R5, R6 and X are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.

GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO

GnRH receptor antagonists are disclosed that have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein n, R1a, R1b, R1c, R2a, R2b, R3, R4, R5, R6 and X are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.